Adaptin Bio Stock Price, News & Analysis
Company Description
Adaptin Bio (OTC Link: APTN) is a publicly traded company.
APTN stock has gained 7.1% over the past year. Shares last traded at $6.00.
On a trailing twelve-month basis, Adaptin Bio and diluted earnings per share of $-0.66.
This page provides a comprehensive overview of APTN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Adaptin Bio (APTN) stock last traded at $6.00. Over the past 12 months, the stock has gained 7.1%.
Latest News
Adaptin Bio has 1 recent news article. View all APTN news →
SEC Filings
Adaptin Bio has filed 5 recent SEC filings, including 1 Form 424B3, 1 Form 10-Q, 1 Form 8-K, 1 Form 10-K. The most recent filing was submitted on May 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all APTN SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.66. With a current ratio of 0.29, short-term liquidity bears monitoring.